勃林格殷格翰的思力华好用吗？

(Repimat) is a new type of long-acting anticholinergic drug. The dissociation speed of the drug from M1 and M3 receptors is 3.5 and 8 times slower than the dissociation speed from M2 receptors respectively. In particular, the dissociation time of M3 receptor reaches 34.7 hours. Therefore, this product can reduce the dissociation rate of M2 cholinergic. Adverse reactions such as bronchoconstriction, salivation and mydriasis caused by receptor blockade can greatly increase the bronchiectasis capacity and prolong the action time, effectively improve the patient's nighttime symptoms, improve the patient's exercise tolerance, and improve the patient's quality of life.

Both the Global Initiative for the Prevention and Treatment of COPD (Chronic Obstructive Pulmonary Disease in Adults) (GOLD) and the American Thoracic Society/European Respiratory Society (AST/ERS) recommend long-acting bronchodilators such as tiotropium as the mainstay of treatment for patients with stable COPD of stage 2 or above. The only disadvantage is that the price is relatively expensive compared to other drugs, but considering the entire treatment process of chronic diseases of patients, Siliva still has its advantages.

In a study conducted in China, the blood gas indicators and serum inflammatory factor levels of the observation group treated with combined medication were better than those of the control group (P<0.05). The patient satisfaction of the observation group was significantly higher than that of the control group (P<0.05). The asthma symptom score was significantly improved, and the COPD symptom score was significantly reduced. The improvement of the observation group was significantly better than that of the control group (P<0.05). Research shows that Seretide combined with Serivata has a good effect in the treatment of chronic obstructive pulmonary disease. After treatment, the relevant indicators of the patients have improved significantly, and there are no adverse reactions during the treatment period, which is highly safe. The combination of the two groups of drugs is an effective method for the treatment of chronic obstructive pulmonary disease.

Boehringer Ingelheim is a century-old German pharmaceutical company. Its independent health care products business in China has excellent brands in cough treatment, constipation treatment and antispasmodic treatment. Boehringer Ingelheim has obvious efficacy and is relatively cheap overseas. Patients can contact Medical Companion Travel to obtain more cost-effective drugs.

Recommended hot articles: /newsDetail/94311.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.